首页 > 最新文献

Archiv Fur Dermatologie Und Syphilis最新文献

英文 中文
Health Equity in Pediatric Drug Development: Translating Aspiration into Operation. 儿科药物开发中的健康公平:将愿望转化为行动。
IF 2 Pub Date : 2022-11-01 Epub Date: 2022-05-20 DOI: 10.1007/s43441-022-00410-3
Morenike Oluwatoyin Folayan, Magda Conway, Carolyn Russo, Nilza Diniz, Lungile P Jafta, Nadia A Sam-Agudu, Sarah Bernays, Victor M Santana, Carla Epps, Mark A Turner

The concept of health equity-the attainment of the highest possible level of health for all members of society-requires equitable access to all aspects of healthcare, including pediatric drug development. However, many communities are under-represented in pediatric drug development programs. Barriers to participation include geographic, economic, racial/ethnic bias, legal, cultural, linguistic, and other factors. While there is no "one size fits all" approach to addressing these barriers, community engagement and collaboration is recognized by the Centers for Disease Control, the World Health Organization, and other global health organizations as a cornerstone for building a more equitable healthcare system. In this article, we will present case studies of stakeholder and community engagement in clinical research for rare diseases and other areas of healthcare, as examples of strategies and practices for actively involving under-represented communities and fostering their participation in pediatric drug development programs. These studies may serve as templates for facilitating equity in pediatric drug development from aspiration into operation.

健康公平的概念是指所有社会成员都能获得尽可能高水平的健康,这就要求人们能公平地获得各方面的医疗保健服务,包括儿科药物开发。然而,许多社区在儿科药物开发项目中的代表性不足。参与的障碍包括地理、经济、种族/民族偏见、法律、文化、语言和其他因素。虽然没有 "放之四海而皆准 "的方法来解决这些障碍,但疾病控制中心、世界卫生组织和其他全球卫生组织都认为,社区参与和合作是建立更公平的医疗保健体系的基石。在本文中,我们将介绍罕见病临床研究和其他医疗保健领域中利益相关者和社区参与的案例研究,作为积极吸引代表性不足的社区并促进其参与儿科药物开发项目的策略和实践的范例。这些研究可作为促进儿科药物开发从愿望到行动的公平性的模板。
{"title":"Health Equity in Pediatric Drug Development: Translating Aspiration into Operation.","authors":"Morenike Oluwatoyin Folayan, Magda Conway, Carolyn Russo, Nilza Diniz, Lungile P Jafta, Nadia A Sam-Agudu, Sarah Bernays, Victor M Santana, Carla Epps, Mark A Turner","doi":"10.1007/s43441-022-00410-3","DOIUrl":"10.1007/s43441-022-00410-3","url":null,"abstract":"<p><p>The concept of health equity-the attainment of the highest possible level of health for all members of society-requires equitable access to all aspects of healthcare, including pediatric drug development. However, many communities are under-represented in pediatric drug development programs. Barriers to participation include geographic, economic, racial/ethnic bias, legal, cultural, linguistic, and other factors. While there is no \"one size fits all\" approach to addressing these barriers, community engagement and collaboration is recognized by the Centers for Disease Control, the World Health Organization, and other global health organizations as a cornerstone for building a more equitable healthcare system. In this article, we will present case studies of stakeholder and community engagement in clinical research for rare diseases and other areas of healthcare, as examples of strategies and practices for actively involving under-represented communities and fostering their participation in pediatric drug development programs. These studies may serve as templates for facilitating equity in pediatric drug development from aspiration into operation.</p>","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"158 1","pages":"991-1003"},"PeriodicalIF":2.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73139085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5T4 oncofoetal antigen: an attractive target for immune intervention in cancer. 5T4胎盘抗原:癌症免疫干预的诱人靶点。
IF 5.8 Pub Date : 2017-04-01 Epub Date: 2016-10-18 DOI: 10.1007/s00262-016-1917-3
Peter L Stern, Richard Harrop

The natural history of a patient's cancer is often characterised by genetic diversity and sequential sweeps of clonal dominance. It is therefore not surprising that identifying the most appropriate tumour-associated antigen for targeted intervention is challenging. The 5T4 oncofoetal antigen was identified by searching for surface molecules shared between human trophoblast and cancer cells with the rationale that they may function to allow survival of the foetus as a semi-allograft in the mother or a tumour in its host. The 5T4 protein is expressed by many different cancers but rarely in normal adult tissues. 5T4 molecules are 72 kD, heavily N-glycosylated proteins with several leucine-rich repeats which are often associated with protein-protein interactions. 5T4 expression is associated with the directional movement of cells through epithelial mesenchymal transition, potentiation of CXCL12/CXCR4 chemotaxis and inhibition of canonical Wnt/beta-catenin while favouring non-canonical pathway signalling; all processes which help drive the spread of cancer cells. The selective pattern of 5T4 tumour expression, association with a tumour-initiating phenotype plus a mechanistic involvement with cancer spread have underwritten the clinical development of different immunotherapeutic strategies including a vaccine, a tumour-targeted superantigen and an antibody drug conjugate. In addition, a chimeric antigen receptor T cell approach targeting 5T4 expressing tumour cells is in pre-clinical development. A key challenge will include how best to combine each 5T4 targeted immunotherapy with the most appropriate standard of care treatment (or adjunct therapy) to maximise the recovery of immune control and ultimately eliminate the tumour.

癌症患者的自然病史通常具有遗传多样性和连续的克隆优势。因此,确定最合适的肿瘤相关抗原进行靶向干预具有挑战性也就不足为奇了。5T4 胎盘抗原是通过寻找人类滋养层细胞和癌细胞共有的表面分子而发现的,其原理是这些分子可能具有使胎儿在母体中作为半异体移植体或肿瘤在宿主体内存活的功能。5T4 蛋白在许多不同的癌症中都有表达,但在正常成人组织中却很少表达。5T4 分子是 72 kD、大量 N-糖基化的蛋白质,具有多个富含亮氨酸的重复序列,通常与蛋白质之间的相互作用有关。5T4 的表达与细胞在上皮间质转化过程中的定向移动、CXCL12/CXCR4 趋化作用的增效、典型 Wnt/beta-catenin 信号的抑制以及非典型途径信号的促进有关;所有这些过程都有助于推动癌细胞的扩散。5T4 肿瘤表达的选择性模式、与肿瘤启动表型的相关性以及与癌症扩散的机理参与,为不同免疫治疗策略(包括疫苗、肿瘤靶向超抗原和抗体药物共轭物)的临床开发提供了基础。此外,一种针对 5T4 表达肿瘤细胞的嵌合抗原受体 T 细胞方法正在进行临床前开发。一个关键的挑战将包括如何将每种 5T4 靶向免疫疗法与最合适的标准治疗(或辅助治疗)进行最佳结合,以最大限度地恢复免疫控制并最终消除肿瘤。
{"title":"5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.","authors":"Peter L Stern, Richard Harrop","doi":"10.1007/s00262-016-1917-3","DOIUrl":"10.1007/s00262-016-1917-3","url":null,"abstract":"<p><p>The natural history of a patient's cancer is often characterised by genetic diversity and sequential sweeps of clonal dominance. It is therefore not surprising that identifying the most appropriate tumour-associated antigen for targeted intervention is challenging. The 5T4 oncofoetal antigen was identified by searching for surface molecules shared between human trophoblast and cancer cells with the rationale that they may function to allow survival of the foetus as a semi-allograft in the mother or a tumour in its host. The 5T4 protein is expressed by many different cancers but rarely in normal adult tissues. 5T4 molecules are 72 kD, heavily N-glycosylated proteins with several leucine-rich repeats which are often associated with protein-protein interactions. 5T4 expression is associated with the directional movement of cells through epithelial mesenchymal transition, potentiation of CXCL12/CXCR4 chemotaxis and inhibition of canonical Wnt/beta-catenin while favouring non-canonical pathway signalling; all processes which help drive the spread of cancer cells. The selective pattern of 5T4 tumour expression, association with a tumour-initiating phenotype plus a mechanistic involvement with cancer spread have underwritten the clinical development of different immunotherapeutic strategies including a vaccine, a tumour-targeted superantigen and an antibody drug conjugate. In addition, a chimeric antigen receptor T cell approach targeting 5T4 expressing tumour cells is in pre-clinical development. A key challenge will include how best to combine each 5T4 targeted immunotherapy with the most appropriate standard of care treatment (or adjunct therapy) to maximise the recovery of immune control and ultimately eliminate the tumour.</p>","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"117 1","pages":"415-426"},"PeriodicalIF":5.8,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11029567/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73120519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterisation of Growth and Ultrastructural Effects of the Xanthoria elegans Photobiont After 1.5 Years of Space Exposure on the International Space Station. 经过国际空间站 1.5 年的太空暴露后,黄龙菌光生体的生长和超微结构效应的特征。
IF 2 Pub Date : 2016-06-01 Epub Date: 2015-11-02 DOI: 10.1007/s11084-015-9470-1
Annette Brandt, Eva Posthoff, Jean-Pierre de Vera, Silvano Onofri, Sieglinde Ott

The lichen Xanthoria elegans has been exposed to space and simulated Mars-analogue environment in the Lichen and Fungi Experiment (LIFE) on the EXPOSE-E facility at the International Space Station (ISS). This long-term exposure of 559 days tested the ability of various organisms to cope with either low earth orbit (LEO) or Mars-analogue conditions, such as vacuum, Mars-analogue atmosphere, rapid temperature cycling, cosmic radiation of up to 215 ± 16 mGy, and insolation of accumulated doses up to 4.87 GJm(-2), including up to 0.314 GJm(-2) of UV irradiation. In a previous study, X. elegans demonstrated considerable resistance towards these conditions by means of photosynthetic activity as well as by post-exposure metabolic activity of 50-80% in the algal and 60-90% in the fungal symbiont (Brandt et al. Int J Astrobiol 14(3):411-425, 2015). The two objectives of the present study were complementary: First, to verify the high post-exposure viability by using a qualitative cultivation assay. Second, to characterise the cellular damages by transmission electron microscopy (TEM) which were caused by the space and Mars-analogue exposure conditions of LIFE. Since the algal symbiont of lichens is considered as the more susceptible partner (de Vera and Ott 2010), the analyses focused on the photobiont. The study demonstrated growth and proliferation of the isolated photobiont after all exposure conditions of LIFE. The ultrastructural analysis of the algal cells provided an insight to cellular damages caused by long-term exposure and highlighted that desiccation-induced breakdown of cellular integrity is more pronounced under the more severe space vacuum than under Mars-analogue atmospheric conditions. In conclusion, desiccation-induced damages were identified as a major threat to the photobiont of X. elegans. Nonetheless, a fraction of the photobiont cells remained cultivable after all exposure conditions tested in LIFE.

在国际空间站(ISS)EXPOSE-E设施的 "地衣和真菌实验"(LIFE)中,Xanthoria elegans地衣暴露在太空和模拟火星环境中。559天的长期暴露测试了各种生物应对低地球轨道(LEO)或火星模拟环境的能力,如真空、火星模拟大气、快速温度循环、高达215 ± 16 mGy的宇宙辐射和累积剂量高达4.87 GJm(-2)的日照,包括高达0.314 GJm(-2)的紫外线辐照。在之前的一项研究中,X. elegans 通过光合作用活性以及暴露后藻类和真菌共生体的新陈代谢活性分别达到 50%-80% 和 60%-90% (Brandt 等,Int J Astrobiol 14(3):411-425,2015 年),证明其对这些条件具有相当强的抵抗力。本研究的两个目标是相辅相成的:首先,通过定性培养试验验证暴露后的高存活率。其次,通过透射电子显微镜(TEM)分析《生命之光》的太空和火星模拟暴露条件对细胞造成的损害。由于地衣的藻类共生体被认为是更易受影响的伙伴(de Vera 和 Ott,2010 年),因此分析重点放在了光生共生体上。研究表明,在 LIFE 的所有暴露条件下,分离出的光生菌体都在生长和增殖。对藻类细胞进行的超微结构分析有助于深入了解长期暴露对细胞造成的损害,并突出表明,与火星类似的大气条件相比,在更为严酷的太空真空条件下,干燥引起的细胞完整性破坏更为明显。总之,干燥引起的损伤被认为是对秀丽隐杆线虫光生体的主要威胁。尽管如此,在 LIFE 中测试的所有暴露条件下,仍有一部分光生菌体细胞可以继续培养。
{"title":"Characterisation of Growth and Ultrastructural Effects of the Xanthoria elegans Photobiont After 1.5 Years of Space Exposure on the International Space Station.","authors":"Annette Brandt, Eva Posthoff, Jean-Pierre de Vera, Silvano Onofri, Sieglinde Ott","doi":"10.1007/s11084-015-9470-1","DOIUrl":"10.1007/s11084-015-9470-1","url":null,"abstract":"<p><p>The lichen Xanthoria elegans has been exposed to space and simulated Mars-analogue environment in the Lichen and Fungi Experiment (LIFE) on the EXPOSE-E facility at the International Space Station (ISS). This long-term exposure of 559 days tested the ability of various organisms to cope with either low earth orbit (LEO) or Mars-analogue conditions, such as vacuum, Mars-analogue atmosphere, rapid temperature cycling, cosmic radiation of up to 215 ± 16 mGy, and insolation of accumulated doses up to 4.87 GJm(-2), including up to 0.314 GJm(-2) of UV irradiation. In a previous study, X. elegans demonstrated considerable resistance towards these conditions by means of photosynthetic activity as well as by post-exposure metabolic activity of 50-80% in the algal and 60-90% in the fungal symbiont (Brandt et al. Int J Astrobiol 14(3):411-425, 2015). The two objectives of the present study were complementary: First, to verify the high post-exposure viability by using a qualitative cultivation assay. Second, to characterise the cellular damages by transmission electron microscopy (TEM) which were caused by the space and Mars-analogue exposure conditions of LIFE. Since the algal symbiont of lichens is considered as the more susceptible partner (de Vera and Ott 2010), the analyses focused on the photobiont. The study demonstrated growth and proliferation of the isolated photobiont after all exposure conditions of LIFE. The ultrastructural analysis of the algal cells provided an insight to cellular damages caused by long-term exposure and highlighted that desiccation-induced breakdown of cellular integrity is more pronounced under the more severe space vacuum than under Mars-analogue atmospheric conditions. In conclusion, desiccation-induced damages were identified as a major threat to the photobiont of X. elegans. Nonetheless, a fraction of the photobiont cells remained cultivable after all exposure conditions tested in LIFE.</p>","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"115 1","pages":"311-21"},"PeriodicalIF":2.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11084-015-9470-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73126699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Verhandlungen der Berliner dermatologischen Vereinigung 柏林皮肤健康协会谈判
Pub Date : 2006-01-01 DOI: 10.1007/BF02445558
{"title":"Verhandlungen der Berliner dermatologischen Vereinigung","authors":"","doi":"10.1007/BF02445558","DOIUrl":"https://doi.org/10.1007/BF02445558","url":null,"abstract":"","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"24 1","pages":"893-911"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02445558","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51923246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Verhandlungen des II. Internationalen Dermatologen-Congresses 商谈II国际Dermatologen-Congresses
Pub Date : 2006-01-01 DOI: 10.1007/BF02445563
{"title":"Verhandlungen des II. Internationalen Dermatologen-Congresses","authors":"","doi":"10.1007/BF02445563","DOIUrl":"https://doi.org/10.1007/BF02445563","url":null,"abstract":"","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"24 1","pages":"985-1029"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02445563","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51923749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Venerische Krankheiten Venerische疾病
Pub Date : 2006-01-01 DOI: 10.1007/BF02445555
Neisser
{"title":"Venerische Krankheiten","authors":"Neisser","doi":"10.1007/BF02445555","DOIUrl":"https://doi.org/10.1007/BF02445555","url":null,"abstract":"","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"24 1","pages":"773-780"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02445555","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51923638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Verhandlungen der Wiener dermatologischen Gesellschaft. 1892 1892年维也纳皮肤学协会谈判
Pub Date : 2006-01-01 DOI: 10.1007/BF02445557
{"title":"Verhandlungen der Wiener dermatologischen Gesellschaft. 1892","authors":"","doi":"10.1007/BF02445557","DOIUrl":"https://doi.org/10.1007/BF02445557","url":null,"abstract":"","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"24 1","pages":"835-892"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02445557","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51923695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beitrag zur Kenntniss der Sclerodermie 6秒
Pub Date : 2006-01-01 DOI: 10.1007/BF02445562
M. Wolters
{"title":"Beitrag zur Kenntniss der Sclerodermie","authors":"M. Wolters","doi":"10.1007/BF02445562","DOIUrl":"https://doi.org/10.1007/BF02445562","url":null,"abstract":"","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"24 1","pages":"943-981"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02445562","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51923310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parasiten und parasitäre Affectionen 寄生虫和寄生虫的情感
Pub Date : 2006-01-01 DOI: 10.1007/BF02445550
{"title":"Parasiten und parasitäre Affectionen","authors":"","doi":"10.1007/BF02445550","DOIUrl":"https://doi.org/10.1007/BF02445550","url":null,"abstract":"","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"24 1","pages":"681"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02445550","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51923477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gonorrhoe und deren Complicationen 铜管及其部
Pub Date : 2006-01-01 DOI: 10.1007/BF02445556
{"title":"Gonorrhoe und deren Complicationen","authors":"","doi":"10.1007/BF02445556","DOIUrl":"https://doi.org/10.1007/BF02445556","url":null,"abstract":"","PeriodicalId":55579,"journal":{"name":"Archiv Fur Dermatologie Und Syphilis","volume":"24 1","pages":"780-834"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02445556","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51923663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archiv Fur Dermatologie Und Syphilis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1